contain risk point still
pt
put miss beat key franchis despit suppli constraint
rais full-year ep rang fx/leverage/tax regard co
bake total impact inclus amount
headwind may may revers year-end busi
prove rel safe-haven coupl tailwind dailies/misight/
paragard rais pt
base hit minim thu far expect apac slow q/q
cc vs headwind predominantli continu
myday suppli constraint biofinity/avaira destock japan post sept
vat increas saw littl impact howev co bake
total impact busi inclus contact len
csi women health account headwind may hit amount
versu top-lin rang left unchang
cc despit headwind expect impact small
due minim direct china exposur total revenu coupl high-
consum mail-ord featur len side busi
misight strong show fit encourag still earli call game changer misight
pediatr myopia control len contribut character
expect support least achiev global target inclus
us year bigger number beyond revenu contribut initi fit
set activ user improv global date last inclus
initi us placement execut side launch invest continu us
rep fulli train februari doc invit misight train march start time
increas dtc/clinical/regulatori cycl still earli outlook
exit also left unchang despit expans us market
grossli conserv includ rate us adopt china/japan clearanc
rais pt safe attract capit goe
reflect headwind
april off-set modest recaptur year-end higher adj om fx/mix benefit
revis prior lower tax revis prior pt goe
prior keep current multipl unchang higher
better rel posit versu medtech/consum peer headwind
coupl continu opportun daili trade-up/misight/paragard
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
growth track ahead contact len market
growth combo launch share gain
continu momentum ahead contact len market
continu sihi daili share gain clariti/myday
materi share loss competit launch
paragard share reach next year
misight launch follow point
market penetr pediatr popul
tax rate remain industri averag
base case pt use ep
growth combo launch share gain
continu momentum ahead contact len market
continu sihi daili share gain clariti/myday
materi share loss competit launch
paragard share reach next year
misight launch follow point
market penetr pediatr popul
tax rate remain industri averag
growth track contact len market
growth combo share loss price cut
clariti/myday loss share competit launch
paragard share stabil next year
tax polici chang result higher effect rate
competit entri amazon contact len
buy thesi predic strong posit
oligopolist contact len industri tailwind
sihi daili trade-up stabil monthly/
custom portfolio attract csi
still under-index
sihi daili
clariti/myday
trade-up weekli daili serv
signific revenu margin tailwind revenu
recent paragard acquisit prior ivf deal drive
misight clinic data us launch
us intern tax polici chang
pleas see import disclosur inform page report
pleas see import disclosur inform page report
eoctjan aprjuloctoctjan aprjuloctoctoctoctocttot growth growth oper interest expens loss tax incom minor interest incom common item tax incom ep fulli growth share exhibit revenu model
pleas see import disclosur inform page report
